Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFPT1 | Q06210 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | GGT1 | P19440 | 4/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527344 | 1.00 | GFPT1 (0.46) | GFPT1ALOX15BLMPMP22KMT2A | |
| SCHEMBL574087 | 1.00 | GFPT1 (0.46) | GFPT1ALOX15BLMPMP22KMT2A | |
| Hydrochloric Acid SCHEMBL503105 | 0.98 | GFPT1 (0.44) | GFPT1ALOX15BLMPMP22KMT2A | |
| Hydrochloric Acid SCHEMBL17239121 | 0.98 | GFPT1 (0.44) | GFPT1ALOX15BLMPMP22KMT2A | |
| Adipic Acid SCHEMBL8055763 | 0.89 | BHMT (0.45) | GFPT1ALOX15BLMPMP22KMT2A | |
| SCHEMBL19371887 | 0.84 | GFPT1 (0.32) | GFPT1 | |
| SCHEMBL22122969 | 0.84 | GFPT1 (0.32) | GFPT1 | |
| SCHEMBL27644228 | 0.84 | SLC7A5 (0.42) | ALOX15BLMPMP22KMT2APTGS1 | |
| SCHEMBL27644223 | 0.84 | SLC7A5 (0.42) | ALOX15BLMPMP22KMT2APTGS1 | |
| SCHEMBL1478033 | 0.82 | SLC7A5 (0.41) | ALOX15BLMPMP22KMT2APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-20260091126-A1 | AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY | UNIV MISSOURI (US) | 2026-04-02 | — | — | US | claimed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | claimed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | claimed |
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | UNIV ERASMUS MED CT ROTTERDAM (NL) | 2025-11-13 | — | — | US | claimed |
| EP-4590670-A1 | PLATFORM AND SCAFFOLD FOR FAP TARGETING AGENTS | Erasmus University Rotterdam Medical Center (NL) | 2025-07-30 | — | — | EP | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| EP-3833676-B1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2025-05-28 | — | — | EP | claimed |
| EP-4529474-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | Erasmus University Rotterdam Medical Center (NL) | 2025-04-02 | — | — | EP | claimed |
| WO-2025063849-A2 | DIMERIC FAP TARGETING AGENTS | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | 2025-03-27 | — | — | WO | claimed |
| EP-1986683-A2 | COMPOSITIONS AND METHODS FOR EFFECTING CONTROLLED POSTERIOR VITREOUS DETACHMENT | Bausch & Lomb Incorporated (US) | 2008-11-05 | — | — | EP | claimed |
| WO-2008098151-A2 | POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME | KEMPHARM, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| US-20070212358-A1 | Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment | BAUSCH & LOMB INCORPORATED | 2007-09-13 | — | — | US | claimed |
| WO-2007101005-A2 | COMPOSITIONS AND METHODS FOR EFFECTING CONTROLLED POSTERIOR VITREOUS DETACHMENT | BAUSCH & LOMB INCORPORATED (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070196350-A1 | Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment | BAUSCH & LOMB INCORPORATED | 2007-08-23 | — | — | US | claimed |
| EP-1189623-B1 | METHOD AND COMPOSITION FOR INHIBITING CARDIOVASCULAR CELL PROLIFERATION | UNIV LELAND STANFORD JUNIOR (US) | 2007-03-14 | — | — | EP | claimed |
| US-20040074504-A1 | Method and composition for inhibiting cardiovascular cell proliferation | COOKE JOHN P (US) | 2004-04-22 | — | — | US | claimed |
| US-6605115-B1 | Method and composition for inhibiting cardiovascular cell proliferation | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2003-08-12 | — | — | US | claimed |
| EP-0561412-B1 | Parathyroid hormone derivatives | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-02-03 | — | — | EP | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | GFPT1 213/4885ALOX15 3961/4885BLM 3782/4885 |
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | SSTR2, SSTR5, SSTR1 | GFPT1 1207/4885ALOX15 4502/4885BLM 3001/4885 |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | GFPT1 1331/4885ALOX15 2769/4885BLM 541/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | GFPT1 1014/4885ALOX15 2512/4885BLM 4297/4885 |
| US-20260091126-A1 | AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY | METTL16, SLC7A1, RNMT | GFPT1 743/4885ALOX15 792/4885BLM 3778/4885 |
| US-12540161-B2 | Linkers | ADM2, CDA, DCTD | GFPT1 2666/4885ALOX15 3617/4885BLM 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.